Publications by authors named "Jason Brayer"

Claim this Profile
T
Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapy.
Mark B Meads, Xiaohong Zhao, David R Noyes, Praneeth Sudalagunta, Alexandra Achille, Jason Brayer

Blood· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple Myeloma.
Rafael Renatino Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, Maria Silva, Xiaohong Zhao, Jason B Brayer

Res Sq· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Functional Transcriptomic Landscape Informs Therapeutic Strategies in Multiple Myeloma.
Praneeth Reddy Sudalagunta, Rafael R Canevarolo, Mark B Meads, Maria Silva, Xiaohong Zhao, Jason Brayer

Cancer Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma.
Ciara L Freeman, Reginald Atkins, Indumathy Varadarajan, Meghan Menges, Jeffrey Edelman, Jason Brayer

Clin Cancer Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma.
Dae Hyun Lee, Abhishek Kumar, Turab Mohammed, Lauren C Peres, Melissa Alsina, Jason Brayer

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial.
David A Sallman, Tessa Kerre, Violaine Havelange, Xavier Poiré, Philippe Lewalle, Jason B Brayer

Lancet Haematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma.
Jennifer M Logue, Lauren C Peres, Hamza Hashmi, Christelle M Colin-Leitzinger, Alexandria M Shrewsbury, Jason B Brayer

Blood Adv· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adding Cyclophosphamide to Bortezomib and Dexamethasone was not Associated With Improved Outcomes of Patients With Newly Diagnosed Light Chain Amyloidosis: A Retrospective Study.
Yumeng Zhang, Lauren Duncanson, Jason Brayer, Frederic Reu, Doris Hansen

Clin Lymphoma Myeloma Leuk· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma.
Lauren C Peres, Christelle M Colin-Leitzinger, Mingxiang Teng, Julie Dutil, Raghunandan R Alugubelli, Jason Brayer

Blood Adv· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myeloma.
Agm Mostofa, Allison Distler, Mark B Meads, Eva Sahakian, John J Powers, Jason Brayer

JCI Insight· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dimensional Flow Cytometry Analysis of Regulatory Receptors on Human T Cells, NK Cells, and NKT Cells.
Ryosuke Nakagawa, Jason Brayer, Nicole Restrepo, James J Mulé, Adam W Mailloux

Methods Mol Biol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide-based response-adapted therapy for older adults without high risk myeloma.
Rachid Baz, Syeda Mahrukh Hussnain Naqvi, Jae-Hoon Lee, Jason Brayer, Nancy Hillgruber

Br J Haematol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OMIP-049: Analysis of Human Myelopoiesis and Myeloid Neoplasms.
Genyuan Zhu, Jason Brayer, Eric Padron, James J Mulé, Adam W Mailloux

Cytometry A· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient.
David A Sallman, Jason Brayer, Elizabeth M Sagatys, Caroline Lonez, Eytan Breman

Haematologica· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Connecting the Dots: A Case of Myeloid Sarcoma.
Ashley Rose, Jason Brayer

Am J Med· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types.
Caroline Lonez, Bikash Verma, Alain Hendlisz, Philippe Aftimos, Ahmad Awada, Jason B Brayer

BMJ Open· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential of ixazomib, a second-generation proteasome inhibitor, in the treatment of multiple myeloma.
Jason Brayer, Rachid Baz

Ther Adv Hematol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides.
Jason Brayer, Jeffrey E Lancet, John Powers, Alan List, Lodovico Balducci

Am J Hematol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transformation to Hodgkin lymphoma in chronic lymphocytic leukemia coexisting with Epstein-Barr viremia.
Samir Dalia, Jason Brayer, Pedro Horna, Hailing Zhang, Javier Pinilla-Ibarz

Leuk Lymphoma· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regression of metastatic clear cell kidney cancer with interleukin-2 treatment following nivolumab (anti-PD-1) treatment.
Jason Brayer, Mayer Fishman

J Immunother· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing strategies in the immunotherapy of leukemias.
Jason B Brayer, Javier Pinilla-Ibarz

Cancer Control· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced CD8 T cell cross-presentation by macrophages with targeted disruption of STAT3.
Jason Brayer, Fengdong Cheng, Hongwei Wang, Pedro Horna, Ildefonso Vicente-Suarez

Immunol Lett· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR5 ligation by flagellin converts tolerogenic dendritic cells into activating antigen-presenting cells that preferentially induce T-helper 1 responses.
Ildelfonso Vicente-Suarez, Jason Brayer, Alejandro Villagra, Fengdong Cheng, Eduardo M Sotomayor

Immunol Lett· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo disruption of tolerogenic cross-presentation mechanisms uncovers an effective T-cell activation by B-cell lymphomas leading to antitumor immunity.
Pedro Horna, Alex Cuenca, Fengdong Cheng, Jason Brayer, Hong-Wei Wang

Blood· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expansion of myeloid suppressor cells in SHIP-deficient mice represses allogeneic T cell responses.
Tomar Ghansah, Kim H T Paraiso, Steven Highfill, Caroline Desponts, Sarah May, Jason Brayer

J Immunol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis